BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 27576534)

  • 21. Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients.
    Loghavi S; Alayed K; Aladily TN; Zuo Z; Ng SB; Tang G; Hu S; Yin CC; Miranda RN; Medeiros LJ; Khoury JD
    J Hematol Oncol; 2015 Jun; 8():65. PubMed ID: 26055271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relapse of Plasmablastic Lymphoma With Cutaneous Involvement in an Immunocompetent Male.
    Shwe S; Sharma AA; Lee BA; Smith JE
    Ear Nose Throat J; 2022 Jun; 101(5):NP222-NP225. PubMed ID: 32955361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasmablastic Lymphoma of the Small Intestine in an HIV- and EBV-negative Patient.
    Fukuo Y; Shibuya T; Ashizawa K; Ito K; Saeki M; Fukushima H; Takahashi M; Nomura K; Okahara K; Haga K; Akazawa Y; Nomura O; Ogura K; Okubo H; Nagahara A
    Intern Med; 2021 Sep; 60(18):2947-2952. PubMed ID: 33776007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristics and prognostic factors of plasmablastic lymphoma patients: analysis of 135 patients from the LYSA group.
    Tchernonog E; Faurie P; Coppo P; Monjanel H; Bonnet A; Algarte GĂ©nin M; Mercier M; Dupuis J; Bijou F; Herbaux C; Delmer A; Fabiani B; Besson C; Le Gouill S; Gyan E; Laurent C; Ghesquieres H; Cartron G
    Ann Oncol; 2017 Apr; 28(4):843-848. PubMed ID: 28031174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases.
    Morscio J; Dierickx D; Nijs J; Verhoef G; Bittoun E; Vanoeteren X; Wlodarska I; Sagaert X; Tousseyn T
    Am J Surg Pathol; 2014 Jul; 38(7):875-86. PubMed ID: 24832164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Case of plasmablastic lymphoma of the sigmoid colon and literature review.
    Haramura T; Haraguchi M; Irie J; Ito S; Tokai H; Noda K; Kitajima M; Minami S; Inoue K; Sasaki Y; Oshima K; Eguchi S
    World J Gastroenterol; 2015 Jun; 21(24):7598-603. PubMed ID: 26140010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Plasmablastic lymphoma presenting clinical symptoms similar to plasmablastic myeloma].
    Nakaya A; Nagate Y; Toda J; Yamashita Y; Hirose Y; Mori K; Shibayama H
    Rinsho Ketsueki; 2023; 64(4):260-264. PubMed ID: 37121769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasmablastic lymphoma occurring in ulcerative colitis during treatment with immunosuppressive therapy.
    Ogiyama H; Murayama Y; Tsutsui S; Iwasaki T; Kuriyama D; Horiki M; Imanaka K; Kimura H; Inoue M; Iishi H
    Clin J Gastroenterol; 2023 Apr; 16(2):198-205. PubMed ID: 36609818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD138- Plasmablastic Lymphoma: A Multi-institutional Study and Review of the Literature.
    Choudhuri J; Pan Z; Yuan J; Chen M; Wu X; Zheng G; Zhao C; Yuan Y; Agarwal B; Liu J; Ma MY; Wang Y; Shi Y
    Arch Pathol Lab Med; 2023 Jun; 147(6):643-654. PubMed ID: 36161544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral Plasmablastic Lymphoma: A Rare Manifestation of HIV-Related Neoplasm-A Brief Clinical Study.
    Ramyasri M; Singh V; Mohan Rangan N; Roy ID; Tomar K; Desai AP; Yadav R; Krishnan M
    J Craniofac Surg; 2024 Jun; 35(4):e321-e325. PubMed ID: 38363301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathologic characteristics of HIV/AIDS-related plasmablastic lymphoma.
    Wang D; Zheng Y; Zeng D; Yang Y; Zhang X; Feng Y; Lu H
    Int J STD AIDS; 2017 Mar; 28(4):380-388. PubMed ID: 27164966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological analysis of oral plasmablastic lymphoma: A systematic review.
    Rodrigues-Fernandes CI; de Souza LL; Santos-Costa SFD; Silva AMB; Pontes HAR; Lopes MA; de Almeida OP; Brennan PA; Fonseca FP
    J Oral Pathol Med; 2018 Nov; 47(10):915-922. PubMed ID: 29917262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-6-dependent growth in a newly established plasmablastic lymphoma cell line and its therapeutic targets.
    Mine S; Hishima T; Suganuma A; Fukumoto H; Sato Y; Kataoka M; Sekizuka T; Kuroda M; Suzuki T; Hasegawa H; Fukayama M; Katano H
    Sci Rep; 2017 Aug; 7(1):10188. PubMed ID: 28860565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasmablastic lymphoma: from genetics to treatment.
    Frontzek F; Hailfinger S; Lenz G
    Leuk Lymphoma; 2023 Apr; 64(4):799-807. PubMed ID: 36577021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytokeratin expression in plasmablastic lymphoma - a possible diagnostic pitfall in the routine work-up of tumours.
    Huettl KS; Staiger AM; Horn H; Frontzek F; Goodlad JR; Tapia G; Rosenwald A; Klapper W; Fend F; Climent F; Castellvi J; Tzankov A; Dirnhofer S; Baptista MJ; Navarro JT; Anagnostopoulos I; Hartmann W; Lenz G; Ott G
    Histopathology; 2021 May; 78(6):831-837. PubMed ID: 33165992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unraveling the molecular landscape: a comparative analysis of PI3K and MAPK signaling pathways in plasmablastic lymphoma and diffuse large B-cell lymphoma with therapeutic implications.
    Mansoor A; Akhter A; Kamran H; Minoo P; Stewart D
    Hum Pathol; 2023 Nov; 141():102-109. PubMed ID: 37524252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasmablastic lymphoma of the elderly: a clinicopathological comparison with age-related Epstein-Barr virus-associated B cell lymphoproliferative disorder.
    Liu F; Asano N; Tatematsu A; Oyama T; Kitamura K; Suzuki K; Yamamoto K; Sakamoto N; Taniwaki M; Kinoshita T; Nakamura S
    Histopathology; 2012 Dec; 61(6):1183-97. PubMed ID: 22958176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasmablastic lymphoma of bone marrow: Report of a rare case and immunohistochemistry based approach to the diagnosis.
    Sharma P; Sreedharanunni S; Koshy A; Prakash G; Sachdeva MUS; Malhotra P
    Indian J Pathol Microbiol; 2019; 62(1):107-110. PubMed ID: 30706870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical, pathological and molecular features of plasmablastic lymphoma arising in the gastrointestinal tract: A review and reappraisal.
    Sanguedolce F; Zanelli M; Zizzo M; Martino G; Rossi C; Parente P; Ascani S
    Pathol Res Pract; 2020 Jun; 216(6):152973. PubMed ID: 32370987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary plasmablastic lymphoma of the gastrointestinal tract: A series of 13 HIV-negative cases and a review of literature.
    Fu Z; Wang H; Lauwers GY; Jiang K; Jayaratne NL; Bridglal S; Dong N; Wang E; Chen L; Barclift DP; Zhang L
    Ann Diagn Pathol; 2023 Dec; 67():152204. PubMed ID: 37639839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.